A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

NCT00730236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG: AEGR-733

Sponsor

Aegerion Pharmaceuticals, Inc.

Collaborators

[object Object]